Sino Biopharmaceutical Limited (SBMFF)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.67
- As of
Kresmion compiles this page from SBMFF's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Sino Biopharmaceutical Limited/ADR (SBMFF): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and no SEC filing for the company is on record.
See the full SBMFF dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for SBMFF on one page. Preview it with sample data, then open it live with a free account.
Preview the SBMFF dossierActive events for SBMFF
- mediumEarnings below estimates
Q3-2020: Missed consensus by 41.2% - EPS $0.03 vs $0.051 estimate
- mediumEarnings below estimates
Missed consensus by 41.2% - EPS $0.03 vs $0.051 estimate
- mediumEarnings above estimates
Q1-2021: Beat consensus by 85.4% - EPS $0.104 vs $0.0561 estimate
- mediumEarnings above estimates
Q2-2021: Beat consensus by 208.1% - EPS $0.33 vs $0.1071 estimate
FREE, NO ACCOUNT
Every event on SBMFF, as it fires
New filings, 13F moves and cross asset events on SBMFF land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter.
More data on SBMFF
Cite this data
Kresmion counts the managers it follows that reported a non-option position in SBMFF on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on SBMFF in the last 180 days.
Upstream: SEC EDGAR filings for SBMFF
Kresmion, "Sino Biopharmaceutical Limited/ADR (SBMFF) institutional holdings and SEC filings", data as of 2026-06-19, https://kresmion.com/research/SBMFF. Upstream data: SEC EDGAR filings for SBMFF.
Link to this data (HTML):
<a href="https://kresmion.com/research/SBMFF">Sino Biopharmaceutical Limited/ADR (SBMFF) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow SBMFF on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to SBMFF for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.